Quantcast

East and Central Asia

Takeda recognized in the 2019 Dow Jones Sustainability World Index

Takeda has been named in the Dow Jones Sustainabilitz World Index, having more than double the average overall industry score, the company said in a press release Wednesday, noting it was also named in Dow Jones Sustainability Asia Pacific Index for 10th Consecutive Year.

Posted in Asia, news, North America | Tagged | Leave a comment

Daiichi Sankyo’s U3-1402 show reduction in tumor size in testing

Daiichi Sankyo’s test of HER3 antibody drug conjugate U3-1402 data suggest that targeting HER3 with may be an effective treatment strategy irrespective of mechanism of resistance identified in the setting of EGFR TKI resistance, where new precision treatments are needed, said Helena Yu, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center, and a trial investigator.

Posted in Asia, Europe, news | Tagged , , | Leave a comment

Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Peritoneal Carcinomatosis

BEIJING–(BUSINESS WIRE)–Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient

Posted in Asia, news | Tagged | Leave a comment

Covance Unveils New R&D Center in Shanghai

Inauguration Ceremony Highlights World-Class, Comprehensive Drug Development Capabilities and More Than Two Decades of Growth in China BURLINGTON, N.C.–(BUSINESS WIRE)–LabCorp®

Posted in Asia, news | Tagged | Leave a comment

MicuRx Pharmaceuticals Reports Positive Top-Line Results From a US Phase 2 ABSSSI Clinical Trial of Novel Antibiotic Contezolid Acefosamil

FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–MicuRx Pharmaceuticals, Inc., today announced positive top-line results for study MRX4-201, a US Phase 2

Posted in Asia, news | Tagged , | Leave a comment

Trovagene with new data from testing onvansertib with Zytiga for certain prostate cancer

Trovagene will present new clinical data from its Phase 2 trial of onvansertib, in combination with Zytiga (abiraterone acetate)/prednisone, in

Posted in Asia, news | Tagged , , | Leave a comment

DelMar’s cancer treatment show clinical activity against a range of cancers

DelMar Pharmaceuticals said Tuesday that 17 of the first 20 enrolled patients have received at least their first assessment, and nine have been assessed as having achieved a complete response (CR) (9/17, or 53%), seven have been assessed with stable disease (SD), (7/17, or 41%), while nine has been assessed as disease progression (PD) (1/17, or 6%).

Posted in Asia, news | Tagged , | Leave a comment

Inovio publishes positive results from the first-in-human trial of its vaccine against the MERS

Inovio Pharmaceuticals published its positive results from the first-in-human trial of its vaccine against the Middle East Respiratory Syndrome Coronavirus

Posted in Asia, news | Tagged | Leave a comment

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together

Posted in Asia, news, North America | Tagged , | Leave a comment

Akebia Therapeutics submitts Vadadustat New Drug Application in Japan for Anemia Due to Chronic Kidney Disease by Collaboration Partner, MTPC

JNDA Submission Represents First Regulatory Submission for Marketing Approval of Vadadustat CAMBRIDGE, Mass.–(BUSINESS WIRE)–Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced

Posted in Asia, news | Tagged | Leave a comment